Clinical and pathological features of microscopic polyangiitis in 20 children

Journal of Rheumatology

Volumn 41, Issue 8, 2014, Pages 1712-1719

  Sun, Liangzhong ^a   Wang, Haiyan ^a   Jiang, Xiaoyun ^a   Mo, Ying ^a   Yue, Zhihui ^a   Huang, Liuyi ^a   Liu, Ting ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Antineutrophil cytoplasmic antibodies; Glomerulonephritis; Microscopic polyangiitis; Systemic vasculitis

Indexed keywords

CYCLOPHOSPHAMIDE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; STEROID; ANTITHYROID AGENT; BIOLOGICAL MARKER; PEROXIDASE;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG PULSE THERAPY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MALE; MICROSCOPIC POLYANGIITIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN DISEASE; TREATMENT DURATION; BIOPSY; BLOOD; CHEMICALLY INDUCED; DRUG COMBINATION; GLOMERULUS; PATHOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME; VASCULARIZATION;

ADOLESCENT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KIDNEY GLOMERULUS; MALE; MICROSCOPIC POLYANGIITIS; PEROXIDASE; PULSE THERAPY, DRUG; RETROSPECTIVE STUDIES; STEROIDS; TREATMENT OUTCOME;

EID: 84905457467     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.131300     Document Type: Article

References (29)

1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11.
2. Dedeoglu F. Drug-induced autoimmunity. Curr Opin Rheumatol 2009;21:547-51.
3. Yamato K, Ishii T, Kawamura T. Microscopic polyangiitis in a girl with severe anemia and no respiratory symptoms. Pediatr Int 2012;54:541-3.
4. Yu F, Chen M, Gao Y, Wang SX, Zou WZ, Zhao MH, et al. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis. Am J Kidney Dis 2007;49:607-14.
5. Yu F, Chen M, Wang SX, Zou WZ, Zhao MH, Wang HY. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney. Nephrology 2007;12:74-80.
6. Garcia NV, Hernandez L, Haddad JC, Garcia PJ, Ramos P. [Experience of a renal function test unit].[Article in Spanish] Nefrologia 2000;20:54-8.
7. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-100.
8. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987;34:571-90.
9. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-76.
10. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-8.
11. Flossmann O, Bacon P, de Groot K, Jayne D, Rasmussen N, Seo P, et al. Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 2007;66:283-92.
12. Bosch X, Guilabert A, Espinosa G, Mirapeix E. Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA 2007;298:655-69.
13. Yu F, Huang JP, Zou WZ, Zhao MH. The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children. Pediatr Nephrol 2006;21:497-502.
14. Chen M, Yu F, Zhang Y, Zhao MH. Clinical [corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre. Postgrad Med J 2005;81:723-7.
15. Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007;66:605-17.
16. Watts RA, Mooney J, Skinner J, Scott DG, Macgregor AJ. The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis. Rheumatology 2012;51:926-31.
17. Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG, et al.Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U. K. Rheumatology 2011;50:1916-20.
18. Yu F, Zhao MH, Huang JP, Yao Y, Zou WZ, Zhang YK, et al. [Clinical and pathological features of anti-neutrophil cytoplasm antibody associated systemic vasculitis in children]. [Article in Chinese] Zhonghua Er Ke Za Zhi 2003;41:831-4.
19. Visavachaipan N, Ong-Ajyooth L, Chanchairujuira T, Parichatikanond P, Choensuchon B. Clinical features and outcomes in patient with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment in Siriraj Hospital. J Med Assoc Thai 2010;93 Suppl 1:S139-46.
20. Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, et al. Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 2002;62:1732-42.
21. Peco-Antic A, Bonaci-Nikolic B, Basta-Jovanovic G, Kostic M, Markovic-Lipkovski J, Nikolic M, et al. Childhood microscopic polyangiitis associated with MPO-ANCA. Pediatr Nephrol 2006;21:46-53.
22. Noh JY, Yasuda S, Sato S, Matsumoto M, Kunii Y, Noguchi Y, et al. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab 2009;94:2806-11.
23. Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet 2006;368:404-18.
24. Bakkaloglu A, Ozen S, Baskin E, Besbas N, Gur-Guven A, Kasapcopur O, et al. The significance of antineutrophil cytoplasmic antibody in microscopic polyangiitis and classic polyarteritis nodosa. Arch Dis Child 2001;85:427-30.
25. Fujieda M, Hattori M, Kurayama H, Koitabashi Y. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J Am Soc Nephrol 2002;13:437-45.
26. Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, et al. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 2012;64:3452-62.
27. Gunton JE, Stiel J, Clifton-Bligh P, Wilmshurst E, McElduff A. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol 2000;142:587.
28. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009;68:310-7.
29. Krmar RT, Kågebrand M, Hansson ME, Halling SE, Åsling-Monemi K, Herthelius M, et al. Renal-limited vasculitis in children: a single-center retrospective long-term follow-up analysis. Clin Nephrol 2013;80:388-94.